Form 13D/A Health Catalyst For: 13 March
#Form 13D/A #Health Catalyst #SEC filing #ownership disclosure #investment amendment
📌 Key Takeaways
- A Form 13D/A was filed for Health Catalyst on March 13, indicating a significant change in ownership or investment stance.
- The filing is an amendment to a previous Schedule 13D, which is required for investors holding more than 5% of a company's stock.
- Such amendments often signal shifts in investor strategy, such as buying, selling, or changes in investment purpose.
- The filing date, March 13, marks the official submission of this updated ownership information to regulatory authorities.
🏷️ Themes
Regulatory Filing, Investment Activity
📚 Related People & Topics
SEC filing
Type of financial statements in the United States
# SEC Filing An **SEC filing** is a formal financial statement or regulatory document submitted to the **U.S. Securities and Exchange Commission (SEC)**. These filings are mandatory requirements designed to ensure transparency, providing a standardized method for disclosing material information to ...
Entity Intersection Graph
Connections for SEC filing:
Mentioned Entities
Deep Analysis
Why It Matters
This SEC filing matters because it signals significant ownership changes by institutional investors in Health Catalyst, potentially indicating strategic shifts in investment positions. It affects Health Catalyst shareholders, company management, and market analysts tracking healthcare technology investments. The timing of the filing during March suggests quarterly portfolio adjustments that could influence stock volatility. Understanding these ownership changes helps investors gauge institutional confidence in the company's direction and valuation.
Context & Background
- Form 13D/A is an amended Schedule 13D filing required by the SEC when ownership exceeds 5% of a company's shares and material changes occur in the investor's position.
- Health Catalyst is a healthcare data and analytics company that went public in 2019, providing technology solutions to hospitals and health systems.
- Schedule 13D filings are distinct from 13G filings—13D indicates active or influential investment intent, while 13G indicates passive investment.
- Previous 13D filings for Health Catalyst have included major institutional investors like Viking Global Investors and FMR LLC (Fidelity).
- The healthcare technology sector has seen increased investor interest due to digital transformation trends accelerated by the COVID-19 pandemic.
What Happens Next
Market analysts will scrutinize the amended filing details to identify which investor changed their position and whether it represents increased or decreased ownership. Health Catalyst's stock may experience short-term trading volatility as the market digests the ownership change implications. The company's next earnings call (likely in May 2024) may include questions from analysts about institutional investor sentiment and strategic implications.
Frequently Asked Questions
Form 13D is the initial filing when an investor acquires more than 5% of a company's shares with activist intent. Form 13D/A is an amendment filed when material changes occur to the previously reported ownership position or investment strategy.
Investors file Schedule 13D to disclose significant ownership stakes and their intentions regarding the company. This transparency requirement helps prevent market manipulation and informs other shareholders about potential influential investors.
SEC regulations require amendments to be filed promptly after material changes occur, typically within 2 business days. The March 13 filing date suggests the ownership change happened around March 11-12.
Material changes triggering amendments include acquiring or disposing of 1% or more of shares, changes in investment purpose (from passive to activist), or modifications to agreements regarding company control.
Individual investors should monitor whether the filing indicates increased institutional confidence or potential activist pressure. Large ownership changes can influence stock liquidity, volatility, and potentially corporate strategy decisions.